Alvotech (ALVO) EBT (2021 - 2025)

Alvotech has reported EBT for 5 years, with the latest figure at $309.5 million in Q4 2025.

• For the quarter ending Q4 2025, EBT rose 242.24% year-over-year to $309.5 million; the trailing twelve-month figure through Dec 2025 stood at $136.3 million (up 134.9% YoY), and the FY2025 full-year result was $136.3 million, up 162.67% from the prior year.
• EBT for Q4 2025 stood at $309.5 million, up from -$275.9 million in the prior quarter.
• The five-year high for EBT was $327.9 million in Q2 2025, with the low at -$651.0 million in Q4 2023.
• Historically, EBT has averaged -$110.2 million across 5 years, with a median of -$121.4 million in 2022.
• The largest YoY upside for EBT was 321.33% in 2025 against a maximum downside of 99900.0% in 2025.
• Alvotech's EBT stood at $254.0 million in 2021, then plunged by 317.17% to -$551.6 million in 2022, then decreased by 18.02% to -$651.0 million in 2023, then jumped by 66.58% to -$217.6 million in 2024, then surged by 242.24% to $309.5 million in 2025.
• The last three EBT figures came in at $309.5 million (Q4 2025), -$275.9 million (Q3 2025), and $327.9 million (Q2 2025), per Business Quant data.